Long-Term Debt: The sum of all long term debt fields.
Phathom Pharmaceuticals, Inc. (PHAT) had Long-Term Debt of $209.09M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$175.11M |
|
$-221.25M |
|
$22.60M |
|
$152.51M |
|
$335.10M |
|
$-159.99M |
|
$-61.26M |
|
$-221.25M |
|
$-221.25M |
|
$-221.25M |
|
$-221.25M |
|
$-221.25M |
|
$-221.25M |
|
$-159.99M |
|
$-156.34M |
|
72.92M |
|
72.92M |
|
$-3.03 |
|
$-3.03 |
|
| Balance Sheet Financials | |
$228.97M |
|
$1.06M |
|
$30.18M |
|
$259.15M |
|
$132.04M |
|
|
Long-Term Debt |
$209.09M |
$565.27M |
|
$697.32M |
|
$-438.17M |
|
$-438.17M |
|
$-438.17M |
|
71.42M |
|
| Cash Flow Statement Financials | |
$-166.78M |
|
$-0.23M |
|
$-0.29M |
|
$300.12M |
|
$132.83M |
|
$-167.29M |
|
$28.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.73 |
|
-- |
|
-- |
|
-0.91 |
|
-0.48 |
|
87.09% |
|
-91.36% |
|
-91.36% |
|
-89.28% |
|
-126.35% |
|
-126.35% |
|
$-167.00M |
|
-- |
|
-- |
|
-- |
|
0.68 |
|
4.10 |
|
2.24 |
|
162.85 |
|
50.49% |
|
50.49% |
|
-85.37% |
|
96.58% |
|
$-6.14 |
|
$-2.29 |
|
$-2.29 |
|